Patent ID: 8907130

Claim:
A β-hydroxyalkylamide, comprising two or three or four β-hydroxyalkylamide groups per molecule of the formula I: wherein: R 1 and R 2 independently of one another are identical or different radicals selected from the group consisting of an alkyl radical, a cycloalkyl radical, an aryl radical, an aralkyl radical and an alkenyl radical having 1-24 carbon atoms, such that the radicals optionally comprise a heteroatom, functional group, or both, R 1 is optionally a hydrogen, and R 2 is optionally represented by the formula: A is represented by A 1 : wherein radicals R 3 independently of one another are identical or different radicals selected from the group consisting of hydrogen, an alkyl radical, a cycloalkyl radical, an aryl radical, an aralkyl radical, and an alkenyl radical having 1-24 carbon atoms, such that the radicals optionally comprise a heteroatom, a functional group, or both, and two or more substituents R 3 are optionally linked with one another to form rings; the β-hydroxyalkylamide is present in solid form below 150° C.; wherein the β-hydroxyalkylamide has a trans content of greater than or equal to 70 mol % based on the total amount of all of the isomers of the β-hydroxyalkylamide; wherein the β-hydroxyalkylamide has two endothermic peaks according to DSC analysis (differential scanning calorimetry), where peak 1 is situated in the region of 140-170° C., with a maximum of 155-165° C., and peak 2 is situated in the region of 170-210° C., with a maximum of 175-207° C.; and wherein a ratio of the enthalpies of endothermic peak 1 to endothermic peak 2 is 1:1 to 1:5.